Takeda Pharmaceutical Co Ltd ADR Earnings

The next earnings date for Takeda Pharmaceutical Co Ltd ADR is July 28, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Takeda Pharmaceutical Co Ltd ADR Earnings

Report Date	Estimated Earnings Per Share
07/28/2026	$60.71

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Takeda Pharmaceutical Co Ltd ADR Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
05/13/2026	---	$-15.56	35.85%
01/30/2026	---	$65.65	90.61%
10/30/2025	---	$-7.48	-121.92%
07/30/2025	---	$79.40	38.94%
05/08/2025	---	$-65.35	-17.13%
01/30/2025	---	$14.86	-41.58%
10/31/2024	---	$58.14	75.50%
07/31/2024	---	$60.71	37.34%
05/09/2024	---	$-2.01	-357.79%
02/01/2024	---	$67.59	134.84%
10/26/2023	---	$-31	-184.23%
07/27/2023	---	$57.51	-17.69%
05/11/2023	---	$20.03	47.57%
02/02/2023	---	$76.70	1.89%
10/27/2022	---	$39.75	2.91%
07/28/2022	---	$67.94	-5.43%
05/11/2022	---	$-6.95	-215.36%
02/03/2022	---	$37.01	-27.54%
10/28/2021	---	$29.24	-38.79%
07/30/2021	---	$87.96	29.40%
05/11/2021	---	$126.08	160.51%
02/04/2021	---	$59.09	34.83%
10/29/2020	---	$2.20	-93.31%
07/31/2020	---	$52.93	226.71%
05/13/2020	---	$1.10	101.04%
02/04/2020	---	$5.99	119.60%
10/31/2019	---	$34.60	173.52%
07/31/2019	---	$-13.28	69.77%
05/14/2019	---	$-96.37	-19.81%
10/31/2018	---	$61.71	62.53%
07/31/2018	---	$100.05	42.98%
05/14/2018	---	$-69.15	4.17%
02/01/2018	---	$87.16	88.55%
11/01/2017	---	$35.89	82.54%
07/28/2017	---	$185.61	39.26%
05/10/2017	After Market	$-64.93	29.28%
02/01/2017	---	$53.01	170.86%
10/28/2016	---	$31.77	14.98%
07/29/2016	---	$127.30	18.86%
05/10/2016	---	$-42.73	17.76%
02/03/2016	---	$75.60	148.88%
10/30/2015	---	$38.02	-19.48%
07/30/2015	---	$31.32	-20.84%
05/16/2015	Before Market	$-286.76	0.52%
02/05/2015	---	$23.32	-47.58%
10/30/2014	After Market	$35.67	1.78%
08/01/2014	---	$42.40	-12.90%
05/09/2014	---	$-5.50	-75.66%
02/05/2014	Before Market	$58.64	40.24%
10/31/2013	Before Market	$45.13	96.85%
07/31/2013	---	$36.83	24.03%
05/09/2013	---	$-9.71	-136.99%
02/04/2013	---	$24.22	-25.99%
10/31/2012	---	$40.82	8.01%
07/30/2012	---	$110.92	0.40%
05/11/2012	---	$-46.17	-227.46%
02/01/2012	---	$31.61	-22.34%
11/04/2011	---	$76.10	-29.53%
07/29/2011	---	$95.75	8.72%
05/11/2011	---	$41.02	6.41%
02/03/2011	---	$90.30	13.60%
10/29/2010	---	$101.47	20.32%
07/30/2010	---	$81.22	-0.84%
05/12/2010	Before Market	$48.89	66.92%
10/30/2009	Before Market	$97.60	62.68%
07/31/2009	Before Market	$142.64	35.15%
02/03/2009	---	$119.62	17.96%
11/04/2008	---	$84.32	0.83%
07/31/2008	After Market	$3.01	112.74%

More About Takeda Pharmaceutical Co Ltd ADR

Website

https://www.takeda.com

Country

USA

Full Time Employees

47,029

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Takhzyro, Advate, Elaprase, Replagal, Vpriv, Adynovate/Adynovi, Livtencity, ADZYNMA, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Flexbumin, Adcetris, Leuplin/Enantone, Ninlaro, Iclusig, FRUZAQLA, Alunbrig, vyvanse/elvanse, Trintellix, and QDENGA brands. It has licensing and collaboration for the development and commercialization of products with Arrowhead Pharmaceuticals, Cour Pharmaceuticals, Engitix, Halozyme, Mirum Pharmaceuticals, Ucsd/Fortis Advisors, Zedira/Dr. Falk Pharma, Ac Immune, Acurastem, Anima Biotech, Biomarin, Denali Therapeutics, Luxna Biotech, Neurocrine Biosciences, Peptidream, Abbvie, Adimab, Ascentage Pharma, Crescendo Biologics, Exelixis, F-Star, Gsk, Heidelberg Pharma, Innovent Biologics, Keros Therapeutics, Kumquat Biosciences, Protagonist Therapeutics, Halozyme, Kamada, Johnson & Johnson/Momenta Pharmaceuticals, Previpharma, Novavax, Bridgene Biosciences, Charles River Laboratories, Iambic Therapeutics, Ipsen, Km Biologics, Massachusetts Institute Of Technology, and Nabla Bio. The company operates in Japan, the United States. Europe, Canada, Latin America, China, Asia, Russia/Commonwealth of Independent States, the Middle East, Oceania, and Africa. The company was founded in 1781 and is headquartered in Chuo, Japan.

“Takeda Pharmaceutical Co Ltd ADR Earnings” Can Refer to the Takeda Pharmaceutical Co Ltd ADR Earnings Date

Some people say “Takeda Pharmaceutical Co Ltd ADR earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Takeda Pharmaceutical Co Ltd ADR position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Takeda Pharmaceutical Co Ltd ADR Stock on the Earnings Date

If you own Takeda Pharmaceutical Co Ltd ADR stock (TAK) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Takeda Pharmaceutical Co Ltd ADR might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Takeda Pharmaceutical Co Ltd ADR shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Takeda Pharmaceutical Co Ltd ADR Earnings

You can contact us any time if you would like to ask questions about Takeda Pharmaceutical Co Ltd ADR earnings or anything else related to the stock market.